OKUR

OnKure Therapeutics

2.58 USD
-0.04
1.53%
At close Updated Nov 21, 4:00 PM EST
1 day
-1.53%
5 days
-16.5%
1 month
-14%
3 months
-4.8%
6 months
14.67%
Year to date
-69.72%
1 year
-83.86%
5 years
-98.14%
10 years
-98.14%
 

About: OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing top-tier precision medicines that target biologically validated drivers of cancers that are underserved by available therapies. The company operates in one operating segment which is clinical research.

Employees: 46

0
Funds holding %
of 7,447 funds
0
Analysts bullish %
of 1 analysts
Positive news %
of articles
Price charts implemented using Lightweight Charts™